Perivascular Mast Cells Promote Atherogenesis and Induce Plaque Destabilization in Apolipoprotein E–Deficient Mice

Background— Mast cells are major effector cells in allergy and host defense responses. Their increased number and state of activation in perivascular tissue during atherosclerosis may point to a role in cardiovascular disorders. In the present study, we investigated the contribution of perivascular mast cells to atherogenesis and plaque stability in apolipoprotein E–deficient mice. Methods and Results— We show here that episodes of systemic mast cell activation during plaque progression in mice leads to robust plaque expansion. Targeted activation of perivascular mast cells in advanced plaques sharply increases the incidence of intraplaque hemorrhage, macrophage apoptosis, vascular leakage, and CXCR2/VLA-4–mediated recruitment of leukocytes to the plaque. Importantly, treatment with the mast cell stabilizer cromolyn does prevent all the adverse phenomena elicited by mast cell activation. Conclusions— This is the first study to demonstrate that mast cells play a crucial role in plaque progression and destabilization in vivo. We propose that mast cell stabilization could be a new therapeutic approach to the prevention of acute coronary syndromes.

[1]  P. Kovanen,et al.  Mast cell chymase induces smooth muscle cell apoptosis by disrupting NF-kappaB-mediated survival signaling. , 2006, Experimental cell research.

[2]  C. Chen,et al.  Mast cell-deficient W-sash c-kit mutant Kit W-sh/W-sh mice as a model for investigating mast cell biology in vivo. , 2005, The American journal of pathology.

[3]  Jurgen Seppen,et al.  Endothelial KLF2 links local arterial shear stress levels to the expression of vascular tone-regulating genes. , 2005, The American journal of pathology.

[4]  P. Kovanen,et al.  Mast cells in vulnerable coronary plaques: potential mechanisms linking mast cell activation to plaque erosion and rupture , 2004, Current opinion in lipidology.

[5]  A. Sajantila,et al.  Mast Cells in Neovascularized Human Coronary Plaques Store and Secrete Basic Fibroblast Growth Factor, a Potent Angiogenic Mediator , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[6]  V. Fuster,et al.  Caspase-3 and Tissue Factor Expression in Lipid-Rich Plaque Macrophages: Evidence for Apoptosis as Link Between Inflammation and Atherothrombosis , 2004, Circulation.

[7]  Renu Virmani,et al.  Intraplaque hemorrhage and progression of coronary atheroma. , 2003, The New England journal of medicine.

[8]  J. Kwak,et al.  Pro-apoptotic effect of high concentrations of histamine on human neutrophils. , 2003, International immunopharmacology.

[9]  K. Karalis,et al.  Stress-induced interleukin-6 release in mice is mast cell-dependent and more pronounced in Apolipoprotein E knockout mice. , 2003, Cardiovascular research.

[10]  P. Kovanen,et al.  Mast cell‐mediated apoptosis of endothelial cells in vitro: A paracrine mechanism involving TNF‐α‐mediated down‐regulation of bcl‐2 expression , 2003, Journal of cellular physiology.

[11]  Mark M. Kockx,et al.  Phagocytosis and Macrophage Activation Associated With Hemorrhagic Microvessels in Human Atherosclerosis , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[12]  P. Shah,et al.  Mechanisms of plaque vulnerability and rupture. , 2003, Journal of the American College of Cardiology.

[13]  P. Kovanen,et al.  Mast Cell Chymase Induces Smooth Muscle Cell Apoptosis by a Mechanism Involving Fibronectin Degradation and Disruption of Focal Adhesions , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[14]  P. Libby Inflammation in atherosclerosis , 2002, Nature.

[15]  M. Menger,et al.  Acute mast cell‐dependent neutrophil recruitment in the skin is mediated by KC and LFA‐1: inhibitory mechanisms of dexamethasone , 2002, Journal of leukocyte biology.

[16]  V. Fuster,et al.  Intimomedial Interface Damage and Adventitial Inflammation Is Increased Beneath Disrupted Atherosclerosis in the Aorta: Implications for Plaque Vulnerability , 2002, Circulation.

[17]  M. Bennett APOPTOSIS IN THE CARDIOVASCULAR SYSTEM , 2002, Heart.

[18]  T. V. van Berkel,et al.  Induction of Atherosclerotic Plaque Rupture in Apolipoprotein E−/− Mice After Adenovirus-Mediated Transfer of p53 , 2002, Circulation.

[19]  Steffen Jung,et al.  The chemokine KC, but not monocyte chemoattractant protein-1, triggers monocyte arrest on early atherosclerotic endothelium. , 2001, The Journal of clinical investigation.

[20]  M. Fiore,et al.  Nerve growth factor levels and mast cell distribution in human coronary atherosclerosis. , 2001, Atherosclerosis.

[21]  Peter Libby,et al.  Current Concepts of the Pathogenesis of the Acute Coronary Syndromes , 2001, Circulation.

[22]  T. V. van Berkel,et al.  Induction of Rapid Atherogenesis by Perivascular Carotid Collar Placement in Apolipoprotein E–Deficient and Low-Density Lipoprotein Receptor–Deficient Mice , 2001, Circulation.

[23]  J. Kelley,et al.  The molecular role of mast cells in atherosclerotic cardiovascular disease. , 2000, Molecular medicine today.

[24]  D. Leszczyński,et al.  Mast Cell Chymase Induces Apoptosis of Vascular Smooth Muscle Cells , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[25]  P. Kovanen,et al.  Adventitial mast cells connect with sensory nerve fibers in atherosclerotic coronary arteries. , 2000, Circulation.

[26]  L. Lindbom,et al.  Direct observations in vivo on the role of endothelial selectins and alpha(4) integrin in cytokine-induced leukocyte-endothelium interactions in the mouse aorta. , 2000, Circulation research.

[27]  A. Matsumori,et al.  Mast cells cause apoptosis of cardiomyocytes and proliferation of other intramyocardial cells in vitro. , 1999, Circulation.

[28]  K. Williams,et al.  Atherosclerosis--an inflammatory disease. , 1999, The New England journal of medicine.

[29]  T. Paavonen,et al.  Association between myocardial infarction and the mast cells in the adventitia of the infarct-related coronary artery. , 1999, Circulation.

[30]  G. Angelini,et al.  Activation of matrix-degrading metalloproteinases by mast cell proteases in atherosclerotic plaques. , 1998, Arteriosclerosis, thrombosis, and vascular biology.

[31]  H. Dvorak,et al.  Mast Cells Can Secrete Vascular Permeability Factor/ Vascular Endothelial Cell Growth Factor and Exhibit Enhanced Release after Immunoglobulin E–dependent Upregulation of Fcε Receptor I Expression , 1998, The Journal of experimental medicine.

[32]  K. Koch,et al.  Mast cell infiltration in acute coronary syndromes: implications for plaque rupture. , 1998, Journal of the American College of Cardiology.

[33]  M. Auer,et al.  Transcytosis and Surface Presentation of IL-8 by Venular Endothelial Cells , 1997, Cell.

[34]  P. Kovanen,et al.  Mast cells in rupture-prone areas of human coronary atheromas produce and store TNF-alpha. , 1996, Circulation.

[35]  P. Kovanen,et al.  Mast cells accompany microvessels in human coronary atheromas: implications for intimal neovascularization and hemorrhage. , 1996, Atherosclerosis.

[36]  P. Constantinides Infiltrates of activated mast cells at the site of coronary atheromatous erosion or rupture in myocardial infarction. , 1995, Circulation.

[37]  A. Kraneveld,et al.  Delayed‐type hypersensitivity‐induced increase in vascular permeability in the mouse small intestine: inhibition by depletion of sensory neuropeptides and NK1 receptor blockade , 1995, British journal of pharmacology.

[38]  M. Boros,et al.  ROLE OF HISTAMINE IN THE INTESTINAL FLOW RESPONSE FOLLOWING MESENTERIC ISCHEMIA , 1994, Shock.

[39]  P. Kovanen,et al.  Accumulation of activated mast cells in the shoulder region of human coronary atheroma, the predilection site of atheromatous rupture. , 1994, Circulation.

[40]  D. Schadendorf,et al.  Human mast cells produce IL-8. , 1993, Journal of immunology.

[41]  E. Falk Why do plaques rupture? , 1992, Circulation.

[42]  S. Jonjić,et al.  Site-restricted persistent cytomegalovirus infection after selective long-term depletion of CD4+ T lymphocytes , 1989, The Journal of experimental medicine.

[43]  K. Chung,et al.  Inflammatory mediators involved in antigen-induced airway microvascular leakage in guinea pigs. , 1988, The American review of respiratory disease.

[44]  S. Galli,et al.  Fate of bone marrow-derived cultured mast cells after intracutaneous, intraperitoneal, and intravenous transfer into genetically mast cell- deficient W/Wv mice. Evidence that cultured mast cells can give rise to both connective tissue type and mucosal mast cells , 1985, The Journal of experimental medicine.

[45]  H. Dvorak,et al.  Mast cell clones: a model for the analysis of cellular maturation , 1982, The Journal of cell biology.

[46]  J. Kelley,et al.  Mast cell activation by lipoproteins. , 2006, Methods in molecular biology.

[47]  M. Tsai,et al.  Mast cells as "tunable" effector and immunoregulatory cells: recent advances. , 2005, Annual review of immunology.

[48]  J. Willerson,et al.  Role of inflammation in coronary plaque disruption. , 1994, Circulation.

[49]  G. J. Grega,et al.  Effects of local mast cell degranulation on vascular permeability to macromolecules. , 1991, Microcirculation, endothelium, and lymphatics.

[50]  Grega Gj,et al.  Effects of local mast cell degranulation on vascular permeability to macromolecules. , 1991 .